UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 307

Sortiert nach

Larger Vancomycin Doses (at Least Four Grams per Day) Are Associated with an Increased Incidence of Nephrotoxicity

Antimicrobial Agents and Chemotherapy, 2008-04, Vol.52 (4), p.1330-1336

2008

Link zum Volltext

Verfügbarkeit prüfen

Suppression of Emergence of Resistance in Pathogenic Bacteria: Keeping Our Powder Dry, Part 1

Antimicrobial agents and chemotherapy, 2016-03, Vol.60 (3), p.1183-1193

2016

Link zum Volltext

Verfügbarkeit prüfen

Optimization of Aminoglycoside Therapy

Antimicrobial Agents and Chemotherapy, 2011-06, Vol.55 (6), p.2528-2531

2011

Link zum Volltext

Verfügbarkeit prüfen

Suppression of Emergence of Resistance in Pathogenic Bacteria: Keeping Our Powder Dry, Part 2

Antimicrobial agents and chemotherapy, 2016-03, Vol.60 (3), p.1194-1201

2016

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics and Pharmacodynamics of Antimicrobials

Clinical infectious diseases, 2007-07, Vol.45 (Supplement-1), p.S89-S95

DRUSANO, G. L

2007

Link zum Volltext

Verfügbarkeit prüfen

Prevention of Resistance: A Goal for Dose Selection for Antimicrobial Agents

Clinical infectious diseases, 2003-01, Vol.36 (Supplement-1), p.S42-S50

Drusano, G L

2003

Link zum Volltext

Verfügbarkeit prüfen

Impact of Granulocytes on the Antimicrobial Effect of Tedizolid in a Mouse Thigh Infection Model

Antimicrobial Agents and Chemotherapy, 2011-11, Vol.55 (11), p.5300-5305

2011

Link zum Volltext

Verfügbarkeit prüfen

Piperacillin-Tazobactam for Pseudomonas aeruginosa Infection: Clinical Implications of an Extended-Infusion Dosing Strategy

Clinical infectious diseases, 2007-02, Vol.44 (3), p.357-363

2007

Link zum Volltext

Verfügbarkeit prüfen

In Vivo Pharmacodynamics of Torezolid Phosphate (TR-701), a New Oxazolidinone Antibiotic, against Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureus Strains in a Mouse Thigh Infection Model

Antimicrobial Agents and Chemotherapy, 2011-07, Vol.55 (7), p.3453-3460

2011

Link zum Volltext

Verfügbarkeit prüfen

Determination of the Dynamically Linked Indices of Fosfomycin for Pseudomonas aeruginosa in the Hollow Fiber Infection Model

Antimicrobial agents and chemotherapy, 2018-06, Vol.62 (6)

2018

Link zum Volltext

Verfügbarkeit prüfen

Polymyxin B Pharmacodynamics in the Hollow-Fiber Infection Model: What You See May Not Be What You Get

Antimicrobial agents and chemotherapy, 2021-07, Vol.65 (8), p.e0185320-e0185320

2021

Link zum Volltext

Verfügbarkeit prüfen

The Combination of Fosfomycin plus Meropenem Is Synergistic for Pseudomonas aeruginosa PAO1 in a Hollow-Fiber Infection Model

Antimicrobial agents and chemotherapy, 2018-12, Vol.62 (12)

2018

Link zum Volltext

Verfügbarkeit prüfen

Impact of Meropenem in Combination with Tobramycin in a Murine Model of Pseudomonas aeruginosa Pneumonia

Antimicrobial Agents and Chemotherapy, 2013-06, Vol.57 (6), p.2788-2792

2013

Link zum Volltext

Verfügbarkeit prüfen

Building Optimal Three-Drug Combination Chemotherapy Regimens

Antimicrobial agents and chemotherapy, 2020-10, Vol.64 (11)

2020

Link zum Volltext

Verfügbarkeit prüfen

Penetration of Meropenem into Epithelial Lining Fluid of Patients with Ventilator-Associated Pneumonia

Antimicrobial Agents and Chemotherapy, 2011-04, Vol.55 (4), p.1606-1610

2011

Link zum Volltext

Verfügbarkeit prüfen

Back to the Future: Using Aminoglycosides Again and How to Dose Them Optimally

Clinical infectious diseases, 2007-09, Vol.45 (6), p.753-760

2007

Link zum Volltext

Verfügbarkeit prüfen

Pharmacodynamics of Ceftazidime plus Avibactam against KPC-2-Bearing Isolates of Klebsiella pneumoniae in a Hollow Fiber Infection Model

Antimicrobial agents and chemotherapy, 2019-08, Vol.63 (8)

2019

Link zum Volltext

Verfügbarkeit prüfen

Dose Fractionation of Moxifloxacin for Treatment of Tuberculosis: Impact of Dosing Interval and Elimination Half-Life on Microbial Kill and Resistance Suppression

Antimicrobial agents and chemotherapy, 2021-03, Vol.65 (4)

2021

Link zum Volltext

Verfügbarkeit prüfen

Linezolid Kills Acid-Phase and Nonreplicative-Persister-Phase Mycobacterium tuberculosis in a Hollow-Fiber Infection Model

Antimicrobial agents and chemotherapy, 2018-08, Vol.62 (8)

2018

Link zum Volltext

Verfügbarkeit prüfen

Pharmacodynamics of fosfomycin: insights into clinical use for antimicrobial resistance

Antimicrobial agents and chemotherapy, 2015-09, Vol.59 (9), p.5602-5610

2015

Link zum Volltext

Verfügbarkeit prüfen

Pharmacodynamics of β-Lactamase Inhibition by NXL104 in Combination with Ceftaroline: Examining Organisms with Multiple Types of β-Lactamases

Antimicrobial Agents and Chemotherapy, 2012-01, Vol.56 (1), p.258-270

2012

Link zum Volltext

Verfügbarkeit prüfen

Impact of Burden on Granulocyte Clearance of Bacteria in a Mouse Thigh Infection Model

Antimicrobial Agents and Chemotherapy, 2010-10, Vol.54 (10), p.4368-4372

2010

Link zum Volltext

Verfügbarkeit prüfen

The Funnel: a Screening Technique for Identifying Optimal Two-Drug Combination Chemotherapy Regimens

Antimicrobial agents and chemotherapy, 2021-01, Vol.65 (2)

2021

Link zum Volltext

Verfügbarkeit prüfen

Population Pharmacokinetics of Extended-Infusion Piperacillin-Tazobactam in Hospitalized Patients with Nosocomial Infections

Antimicrobial Agents and Chemotherapy, 2012-08, Vol.56 (8), p.4087-4094

2012

Link zum Volltext

Verfügbarkeit prüfen

Activity of Moxifloxacin against Mycobacterium tuberculosis in Acid Phase and Nonreplicative-Persister Phenotype Phase in a Hollow-Fiber Infection Model

Antimicrobial agents and chemotherapy, 2018-12, Vol.62 (12)

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 307

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(297)
Mit Volltextzugriff
(271)

Publikationsform

Sprache

Englisch
(307)
Japanisch
(36)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(242)
Science & Technology
(242)
Humans
(210)
Microbiology
(193)
Biological And Medical Sciences
(180)
Medical Sciences
(178)
Pharmacology & Pharmacy
(163)
Pharmacology. Drug Treatments
(155)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(144)
Infectious Diseases
(104)
Male
(92)
Microbial Sensitivity Tests
(89)
Female
(84)
Adult
(81)
Pharmacology
(70)
Antibacterial Agents
(68)
Animals
(55)
Middle Aged
(54)
Anti-Bacterial Agents - Pharmacokinetics
(49)
Models, Biological
(47)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Larger Vancomycin Doses (at Least Four Grams per Day) Are Associated with an Increased Incidence of Nephrotoxicity

Suppression of Emergence of Resistance in Pathogenic Bacteria: Keeping Our Powder Dry, Part 1

Optimization of Aminoglycoside Therapy

Suppression of Emergence of Resistance in Pathogenic Bacteria: Keeping Our Powder Dry, Part 2

Pharmacokinetics and Pharmacodynamics of Antimicrobials

Prevention of Resistance: A Goal for Dose Selection for Antimicrobial Agents

Impact of Granulocytes on the Antimicrobial Effect of Tedizolid in a Mouse Thigh Infection Model

Piperacillin-Tazobactam for Pseudomonas aeruginosa Infection: Clinical Implications of an Extended-Infusion Dosing Strategy

In Vivo Pharmacodynamics of Torezolid Phosphate (TR-701), a New Oxazolidinone Antibiotic, against Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureus Strains in a Mouse Thigh Infection Model

Determination of the Dynamically Linked Indices of Fosfomycin for Pseudomonas aeruginosa in the Hollow Fiber Infection Model

Polymyxin B Pharmacodynamics in the Hollow-Fiber Infection Model: What You See May Not Be What You Get

The Combination of Fosfomycin plus Meropenem Is Synergistic for Pseudomonas aeruginosa PAO1 in a Hollow-Fiber Infection Model

Impact of Meropenem in Combination with Tobramycin in a Murine Model of Pseudomonas aeruginosa Pneumonia

Building Optimal Three-Drug Combination Chemotherapy Regimens

Penetration of Meropenem into Epithelial Lining Fluid of Patients with Ventilator-Associated Pneumonia

Back to the Future: Using Aminoglycosides Again and How to Dose Them Optimally

Pharmacodynamics of Ceftazidime plus Avibactam against KPC-2-Bearing Isolates of Klebsiella pneumoniae in a Hollow Fiber Infection Model

Dose Fractionation of Moxifloxacin for Treatment of Tuberculosis: Impact of Dosing Interval and Elimination Half-Life on Microbial Kill and Resistance Suppression

Linezolid Kills Acid-Phase and Nonreplicative-Persister-Phase Mycobacterium tuberculosis in a Hollow-Fiber Infection Model

Pharmacodynamics of fosfomycin: insights into clinical use for antimicrobial resistance

Pharmacodynamics of β-Lactamase Inhibition by NXL104 in Combination with Ceftaroline: Examining Organisms with Multiple Types of β-Lactamases

Impact of Burden on Granulocyte Clearance of Bacteria in a Mouse Thigh Infection Model

The Funnel: a Screening Technique for Identifying Optimal Two-Drug Combination Chemotherapy Regimens

Population Pharmacokinetics of Extended-Infusion Piperacillin-Tazobactam in Hospitalized Patients with Nosocomial Infections

Activity of Moxifloxacin against Mycobacterium tuberculosis in Acid Phase and Nonreplicative-Persister Phenotype Phase in a Hollow-Fiber Infection Model

Suchergebnisse filtern